Saul Yedgar

This inventor holds 30 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Lipid Conjugates. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 1991-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saul Yedgar. Retrieved from https://idiyas.com/inventor/saul-yedgar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 10)

% Patents Active = 70.0

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 1.4

ph-index = 11

Forward Citations = 246(Granted Patents)

Company Filing History:

30 out of 915

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

patents

Years Active: 1991-2024

Loading Chart...

Areas of Expertise:

Lipid Conjugates

Blood Monitoring

Polymer-Conjugated Lipids

Nervous System Treatment

Conjunctivitis Treatment

Allergic Rhinitis

Chronic Rhinosinusitis

Infection Treatment

Phospholipase A.sub.2 Inhibitors

Vascular Diseases

Eye Disorders

Non-Invasive Monitoring

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12042273 - System and method for non-invasive monitoring of blood conditions (2024-07-23),

2. 11911507 - Liposomes comprising polymer-conjugated lipids and related uses (2024-02-27),

3. 11013811 - Lipid-polymer conjugates, their preparation and uses thereof (2021-05-25),

4. 10624851 - Liposomes comprising polymer-conjugated lipids and related uses (2020-04-21),

5. 10179106 - Liposomes comprising polymer-conjugated lipids and related uses (2019-01-15),

6. 9040078 - Use of lipid conjugates in the treatment of diseases of the nervous system (2015-05-26),

7. 9012396 - Use of lipid conjugates in the treatment of conjunctivitis (2015-04-21),

8. 8916539 - Use of lipid conjugates in the treatment of disease (2014-12-23),

9. 8906882 - Lipid conjugates in the treatment of allergic rhinitis (2014-12-09),

10. 8901103 - Use of lipid conjugates in the treatment of diseases (2014-12-02),

11. 8883761 - Use of lipid conjugates in the treatment of diseases associated with vasculature (2014-11-11),

12. 8865878 - Use of lipid conjugates in the treatment of diseases (2014-10-21),

13. 8865681 - Use of lipid conjugates in the treatment of diseases or disorders of the eye (2014-10-21),

14. 8859524 - Lipid conjugates in the treatment of chronic rhinosinusitis (2014-10-14),

15. 8501701 - Use of lipid conjugates in the treatment of disease (2013-08-06),

Title: The Innovative Mind of Saul Yedgar

Introduction: Saul Yedgar, a distinguished inventor hailing from Jerusalem, Israel, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Saul Yedgar's latest patents showcase his expertise in developing cutting-edge solutions for various industries, including telecommunications, biotechnology, and renewable energy.

Career Highlights: With a career spanning over two decades, Saul Yedgar has consistently pushed the boundaries of innovation, holding numerous patents that have revolutionized the way we approach complex challenges in the modern world.

Collaborations: Throughout his career, Saul Yedgar has collaborated with leading research institutions, universities, and multinational corporations to bring his visionary ideas to life. His ability to work across disciplines has led to the creation of groundbreaking technologies that have had a lasting impact on society.

Conclusion: Saul Yedgar's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to think boldly and push the limits of what is possible.

Profile summary based on public USPTO records.